U.S. Specialty Stores Stock News

Sally Beauty Holdings recently reported fiscal fourth quarter and full-year 2025 results, showing net sales of US$3.70 billion and a year-over-year increase in net income and earnings per share, alongside new guidance for steady performance in 2026. A key insight from the announcement is the company's continued investment in digital growth, exclusive brands, and store refresh initiatives, supported by a sizable ongoing share buyback program that has now reduced shares outstanding by over 32%...

Amkor Technology (AMKR) stock is drawing some fresh attention as investors revisit the company’s performance over the past few months. With the stock up 33% in the past 3 months, there is growing curiosity about what might be driving renewed interest. See our latest analysis for Amkor Technology. Momentum is clearly building for Amkor Technology, with the past 90 days seeing a sharp 33% share price return that stands out from a more modest 1-year total shareholder return of nearly 30%. The...

Pfizer (PFE) has been a topic of interest for investors, especially as its stock returned nearly 3% over the past month. Despite some ups and downs this year, the company’s recent performance offers some intriguing signals for those watching the pharmaceutical sector closely. See our latest analysis for Pfizer. Pfizer’s recent 2.75% 1-month share price return hints at shifting sentiment after a stretch of muted performance, following headline-making events such as new product launches and...

Royalty Pharma (RPRX) grabbed investor attention after releasing an improved full-year 2025 outlook, which highlights stronger expected growth. Third quarter results showed higher revenue and continued share buybacks, signaling management’s confidence and a focus on shareholder returns. See our latest analysis for Royalty Pharma. Following these updates, Royalty Pharma’s share price has posted an impressive 51.8% gain since the start of the year, as investors responded to renewed growth...

LiveWire Group, Inc. recently released its third-quarter 2025 results, reporting sales of US$5.7 million and a net loss of US$19.4 million, alongside a revision to its full-year operating loss guidance to US$72 million–US$77 million. This update highlights the company’s ongoing improvements in operating efficiency and sales, paired with continued investment in new product development and market expansion. We'll explore how LiveWire's focus on innovative electric vehicles amid near-term...

Commercial Metals (CMC) shares have hovered in a tight range lately, catching the eye of investors who track the broader steel and materials sector. The company’s recent performance provides some interesting context for those considering exposure to cyclical industries. See our latest analysis for Commercial Metals. CMC’s share price momentum has been solid this year, with a 20% year-to-date gain reflecting improved optimism around construction demand and resilient earnings. However, the...

UnitedHealth Group (UNH) shares have caught the attention of investors this week as the stock continues to navigate an uneven stretch. The company saw a slight dip of 3% over the past month, raising questions about what might come next. See our latest analysis for UnitedHealth Group. UnitedHealth Group’s 1-year total shareholder return has slumped by 44.5%, with the share price sitting at $321.86 as of the latest close. While the last quarter’s 5.9% share price rebound hints at stabilizing...

Wondering if Teradyne is a real bargain or just getting swept up in the market buzz? You are in the right place for a clear look at what the numbers say about its true value. Teradyne’s stock has climbed an impressive 34.3% year-to-date, with a remarkable 66.5% gain over the last 12 months. However, it dipped 6.8% in the past week after a standout 20.5% jump during the past month. Recent headlines have highlighted industry-wide optimism around automation and semiconductor testing, which sent...

Absci (ABSI) has caught attention following its latest quarterly earnings release and a strategic update outlining a focus on ABS-201. New clinical trials are set, and the company is taking active steps to seek external partners for ABS-101. See our latest analysis for Absci. Absci’s recent earnings report and strategic update turned heads, but the share price has been volatile. After a dramatic 1-month share price drop of 43.6%, sentiment rebounded with a one-day lift of 6.8%. While...

U-Haul Holding Company recently reported its second quarter and six-month earnings for 2025, showing higher revenue of US$1.72 billion for the quarter and US$3.35 billion for the six months but a significant decline in net income compared to the prior year. Alongside these results, U-Haul closed its long-operating Little Rock repair shop while opening a new, larger facility in North Little Rock, signaling a shift in regional operations and workforce allocation. With net income declining...

RLX Technology (NYSE:RLX) has seen its stock climb over 10% this week, sparking renewed questions about what is driving investor interest. Recent trading momentum and improving fundamentals are on investors' minds as they evaluate this move. See our latest analysis for RLX Technology. RLX Technology’s lively 11% climb over the past week follows a strong run in 2024 and comes on the back of persistent trading momentum. While the year-to-date share price return stands at 16%, it is RLX’s...

Serve Robotics recently announced Q3 results and updated guidance, spotlighting rapid expansion with 2,000 robots targeted to be deployed by year-end 2025, alongside new partnerships with delivery platforms DoorDash and Uber Eats. The company is entering a new phase of operational scale, underpinned by a significant increase in delivery volume and merchant partners, and expects to achieve a very large increase in annual revenue in 2026. We’ll explore how Serve Robotics’ rapid merchant...

Wondering if CRISPR Therapeutics is a bargain or just a biotech buzzword? You are not alone. Many investors are asking the same question about whether now is the right time to get involved. After an impressive 26.8% gain year-to-date and a respectable 11.2% return over the past year, the stock has pulled back sharply by 26.9% in the last 30 days. This shows how quickly sentiment can shift. Much of this recent volatility has been driven by news around regulatory developments and fresh...

Avantor (AVTR) shares have seen a noticeable shift recently, with investors keeping an eye on the stock after a decline over the past month. This move comes amid ongoing changes in the broader life sciences sector. See our latest analysis for Avantor. Avantor’s share price has had a challenging run, with a 30-day share price return of -17.95% and a year-to-date return of -46.32%. This reflects fading momentum and cautious sentiment in the life sciences sector. Over the past year, the total...

On November 3, 2025, Sila Realty Trust's Board approved a quarterly cash dividend of US$0.40 per share payable on December 4, 2025, and reported third quarter results with US$49.85 million in revenue and US$0.21 in diluted earnings per share from continuing operations, consistent with last year. A key insight is that Sila Realty Trust continues to show modest revenue growth alongside sustained earnings, while maintaining its dividend payout. We'll explore how reaffirming a US$0.40 dividend...

Earlier this month, The Guardian Life Insurance Company of America announced a long-term strategic partnership with Hamilton Lane, under which Hamilton Lane will manage Guardian's nearly US$5 billion private equity portfolio and benefit from future investment commitments of approximately US$500 million per year over the next decade. This collaboration further advances Hamilton Lane's Insurance Solutions platform, with Guardian investment professionals expected to join the firm and new...

BrightSpring Health Services participated in the UBS Global Healthcare Conference on November 11, 2025, with CFO Jennifer A. Phipps and CEO Jon B. Rousseau presenting at the PGA National Resort Hotel in Palm Beach Gardens, Florida. This high-profile engagement was met with a series of positive analyst upgrades from several major institutions, highlighting increased confidence in the company's growth prospects within the healthcare sector. To understand how rising analyst confidence might...

Albemarle Corporation recently reported third-quarter results showing sales of US$1,307.83 million and a net loss of US$160.69 million, with goodwill impairment charges of US$181.07 million for the period ended September 30, 2025. Despite these headwinds, the company’s earnings guidance and plans for asset divestitures signal increased focus on financial flexibility and operational efficiency. We'll explore how Albemarle's efforts to improve financial flexibility through asset divestitures...

Earlier this month, IBM announced breakthroughs in quantum computing at the Quantum Developer Conference, unveiling the new Quantum Nighthawk processor, which is equipped to handle circuits with 30% greater complexity and is expected to launch by late 2025. These advancements reflect IBM's accelerated roadmap toward quantum advantage and fault-tolerant computing, with milestones being achieved ahead of prior projections and signaling growing activity within the sector. We'll examine how...

Celcuity (CELC) is drawing the spotlight after announcing positive topline results from its phase 3 Victoria 1 study. This is a major milestone that aligns with the company’s recent regulatory advances and strengthened financial position. See our latest analysis for Celcuity. Momentum is clearly building for Celcuity, as the stock’s 1-month share price return of 85.25% and soaring 605.86% year-to-date gain reflect rising optimism following its major study win, regulatory progress, and recent...

Boston Scientific (BSX) shares edged lower today, giving back some recent gains after an extended rally over the past month. Investors are now watching how the stock settles into a new trading range following this pullback. See our latest analysis for Boston Scientific. After a strong upward run through the first part of the year, Boston Scientific's share price has cooled off a bit, even as the company continues to post double-digit revenue and earnings growth. Despite today’s dip, momentum...

Dorchester Minerals (DMLP) just went through a tough quarter, reporting a sharp drop in both revenue and net income. The company also lost a key audit committee member, which put its Nasdaq compliance in jeopardy. See our latest analysis for Dorchester Minerals. Dorchester Minerals’ share price has faced heavy pressure this year, with a 31.9% drop year-to-date, largely reflecting investor concerns after both disappointing Q3 numbers and the audit committee shakeup. While the unit price is off...

Earlier this month, Teva Pharmaceutical Industries reported its third quarter 2025 earnings, showing a return to profitability with net income of US$433 million and reaffirmed revenue targets for its key branded product, AUSTEDO, projecting US$2.5 billion in 2027 and peak sales above US$3 billion. The company also adjusted its 2025 full-year revenue guidance downward while disclosing increased intangible asset impairments, highlighting both strengthened near-term financial control and...

In November 2025, National HealthCare Corporation reported third quarter results showing US$382.66 million in revenue, appointed Dr. Lisa Piercey to its Board, affirmed a quarterly dividend of US$0.64 per share, and announced managerial changes following the planned retirement of its President and COO. Dr. Piercey's addition to the board brings extensive operational and public health expertise, complementing the company’s same-facility growth and recent acquisition activity. We'll explore...